Pharmacokinetics and Dosimetry Studies for Optimization of Pretargeted Radioimmunotherapy in CEA-Expressing Advanced Lung Cancer Patients.

Bodet-Milin C, Ferrer L, Rauscher A, Masson D, Rbah-Vidal L, Faivre-Chauvet A, Cerato E, Rousseau C, Hureaux J, Couturier O, Salaün PY, Goldenberg DM, Sharkey RM, Kraeber-Bodéré F, Barbet J

Open source

DOI: 10.3389/fmed.2015.00084
Published: 2015
Container: Frontiers in medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fmed.2015.00084,
  title = {Pharmacokinetics and Dosimetry Studies for Optimization of Pretargeted Radioimmunotherapy in CEA-Expressing Advanced Lung Cancer Patients.},
  author = {Bodet-Milin C and Ferrer L and Rauscher A and Masson D and Rbah-Vidal L and Faivre-Chauvet A and Cerato E and Rousseau C and Hureaux J and Couturier O and Salaün PY and Goldenberg DM and Sharkey RM and Kraeber-Bodéré F and Barbet J},
  year = {2015},
  journal = {Frontiers in medicine},
  doi = {10.3389/fmed.2015.00084},
  url = {https://doi.org/10.3389/fmed.2015.00084}
}

RIS

TY  - JOUR
TI  - Pharmacokinetics and Dosimetry Studies for Optimization of Pretargeted Radioimmunotherapy in CEA-Expressing Advanced Lung Cancer Patients.
AU  - Bodet-Milin C
AU  - Ferrer L
AU  - Rauscher A
AU  - Masson D
AU  - Rbah-Vidal L
AU  - Faivre-Chauvet A
AU  - Cerato E
AU  - Rousseau C
AU  - Hureaux J
AU  - Couturier O
AU  - Salaün PY
AU  - Goldenberg DM
AU  - Sharkey RM
AU  - Kraeber-Bodéré F
AU  - Barbet J
PY  - 2015
JO  - Frontiers in medicine
DO  - 10.3389/fmed.2015.00084
UR  - https://doi.org/10.3389/fmed.2015.00084
ER  -

APA

C, B., L, F., A, R., D, M., L, R., A, F., E, C., C, R., J, H., O, C., PY, S., DM, G., RM, S., F, K., & J, B. (2015). Pharmacokinetics and Dosimetry Studies for Optimization of Pretargeted Radioimmunotherapy in CEA-Expressing Advanced Lung Cancer Patients.. Frontiers in medicine. https://doi.org/10.3389/fmed.2015.00084

Source records

pubmed · retrieved 2026-09-25T06:20:45.399Z